Annarosa Cuccaro

11PUBLICATIONS
178CO-AUTHORS
Medical virologyTumour immunologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Cardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Mar 19, 2026
Underrated, Unvaccinated, Untreated: A Multinational Registry Analysis of Human Metapneumovirus in Hematological Malignancy, Insights From EPICOVIDEHA/EPIRESEHA Registry.

Jon Salmanton-García, Francesco Marchesi, Erica Mackenzie

|Jan 10, 2026
Nodal Marginal Zone Lymphoma with Prominent Expansion of PD-1+ T-Follicular Helper Cells: A Persistent Diagnostic Challenge with a Heterogeneous Mutational Architecture.

Stefania Crisci, Annarosaria De Chiara, Maria Oro

|Nov 29, 2024
PET2-Adapted Therapy in Patients With Advanced-Stage Hodgkin Lymphoma Treated With Frontline ABVD: Searching for the Baby in the Bathwater.

Antonio Pinto, Annarosa Cuccaro, Matteo Bonanni

|Aug 02, 2024
Long-term efficacy and safety of dose-dense and dose-intense ABVD without consolidation radiotherapy in patients with advanced Hodgkin lymphoma: A 15-year follow-up of the ABVDDD-DI phase II study.

Gaetano Corazzelli, Annarosa Cuccaro, Emanuela Morelli

|May 21, 2024
Correction: Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey.

Tobias Lahmer, Jon Salmanton-García, Francesco Marchesi

|Feb 22, 2024
Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey.

Tobias Lahmer, Jon Salmanton-García, Francesco Marchesi

Pageof 2

Frequent Collaborators

6 joint publications

Livio Pagano

5 joint publications

Chiara Cattaneo

5 joint publications

Jon Salmanton-García

5 joint publications

Francesco Marchesi